Search results

Found 150 pages
AUTHOR: PharmaTimes Reporter

6 Feb 2014:

Lilly lead doctor nominations...so far

The first round of nominations for the 2014 PharmaTimes Sales Awards has come in, with a record 1,683 votes from healthcare professionals. - News - PharmaTimes

by PharmaTimes reporter

https://www.pharmatimes.com/news/lilly_lead_doctor_nominations...so_far_1001494

22 Mar 2013:

AstraZeneca announces further layoffs

AstraZeneca has said it plans to shed 2,300 sales and administration jobs, just days after cutting back its R&D workforce by 1,600. - News - PharmaTimes

by PharmaTimes Reporter

https://www.pharmatimes.com/news/astrazeneca_announces_further_layoffs_1004687

28 May 2015:

UK government commits to health spend increases

The UK government will increase its healthcare spending in England by at least £8 billion a year by 2020 and make the NHS a seven-day a week service. - News - PharmaTimes

by PharmaTimes Reporter

https://www.pharmatimes.com/news/uk_government_commits_to_health_spend_increases_971450

19 Sep 2014:

Last chance to enter PT Marketer of the Year

The PharmaTimes Marketer of the Year 2014 competition is open to all marketers, in all positions, from aspiring, to senior, to cross-functional teams. - News - PharmaTimes

by PharmaTimes reporter

https://www.pharmatimes.com/news/last_chance_to_enter_pt_marketer_of_the_year_1002498

26 Sep 2017:

MSD launches once-daily Isentress in the UK

Will be better placed to compete head on with ViiV's rival integrase inhibitor Tivicay - News - PharmaTimes

by PharmaTimes reporter

https://www.pharmatimes.com/news/msd_launches_once-daily_isentress_in_the_uk_1206406

17 May 2017:

Biogen pays $120 million for late-stage stroke treatment Cirara

Strikes licensing deal with Remedy Pharmaceuticals - News - PharmaTimes

by PharmaTimes reporter

https://www.pharmatimes.com/news/biogen_pays_$120_million_for_late-stage_stroke_treatment_cirara_1192987

12 Feb 2013:

Sanofi downplays Regeneron takeover talk

News that Sanofi had started buying up $500 million-worth of shares in partner Regeneron prompted speculation of a possible hostile bid yesterday, despite the French drugmaker's pleas to the contrary. - News - PharmaTimes

by PharmaTimes Reporter

https://www.pharmatimes.com/news/sanofi_downplays_regeneron_takeover_talk_1004427

23 Aug 2013:

Lilly drawn into Chinese corruption investigation

Eli Lilly has become the latest pharma company to be accused in the Chinese press of bribery and corruption. - News - PharmaTimes

by PharmaTimes reporter

https://www.pharmatimes.com/news/lilly_drawn_into_chinese_corruption_investigation_1005587

5 Dec 2014:

EXCLUSIVE: NHS uses ineffective IPF therapy

The NHS could be wasting millions of pounds by off-label use of an ineffective treatment for idiopathic pulmonary fibrosis when a licensed alternative exists, according to data presented at the British Thoracic Society meeting in London. - News -

by PharmaTimes reporter

https://www.pharmatimes.com/news/exclusive_nhs_uses_ineffective_ipf_therapy_1002871

28 Aug 2013:

Roche drug treats dry form of AMD

Roche looks like it could have another candidate for age-related macular degeneration (AMD) in its portfolio after positive results in a Phase II study. - News - PharmaTimes

by PharmaTimes reporter

https://www.pharmatimes.com/news/roche_drug_treats_dry_form_of_amd_1005604